ERBA DIAGNOSTICS's ticker is ERBA and the CUSIP is 29490B101. A total of 1 filers reported holding ERBA DIAGNOSTICS in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,000 | 0.0% | 8,878 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,000 | +100.0% | 8,878 | +300.3% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 2,218 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 2,218 | -40.3% | 0.00% | -100.0% |
| Q3 2016 | $2,000 | -33.3% | 3,718 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | -25.0% | 3,718 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $4,000 | -20.0% | 3,718 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $5,000 | -28.6% | 3,718 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $7,000 | -12.5% | 3,718 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $8,000 | -90.1% | 3,718 | -83.8% | 0.00% | -82.6% |
| Q1 2015 | $81,000 | +125.0% | 23,000 | +100.0% | 0.02% | +15.0% |
| Q4 2014 | $36,000 | -10.0% | 11,500 | 0.0% | 0.02% | -16.7% |
| Q3 2014 | $40,000 | +60.0% | 11,500 | -8.0% | 0.02% | +60.0% |
| Q2 2014 | $25,000 | -21.9% | 12,500 | 0.0% | 0.02% | -28.6% |
| Q1 2014 | $32,000 | -22.0% | 12,500 | -16.7% | 0.02% | -25.0% |
| Q4 2013 | $41,000 | – | 15,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Investment Advisors, LLC | 3,718 | $8,000 | 0.00% |
| Creative Planning | 135,000 | $296,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 24,996 | $55,000 | 0.00% |
| SEGALL BRYANT & HAMILL, LLC | 12,000 | $26,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 39,019 | $85,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,000 | $2,000 | 0.00% |
| NORTHERN TRUST CORP | 17,252 | $38,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 54,497 | $119,000 | 0.00% |
| BlackRock Investment Management, LLC | 1,321 | $3,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,069 | $2,000 | 0.00% |